Bridging Australia and the Arab World

Sunday, 22 November 2026

AMA Calls for Health Review of Salmon Antibiotic Permit

AMA Calls for Health Review of Salmon Antibiotic Permit
Spread the love

Arabic version: الجمعية الطبية الأسترالية تطالب بمراجعة صحية لتصريح مضاد حيوي للسلمون

According to ABC News, the Australian Medical Association has urged the Australian Pesticides and Veterinary Medicines Authority to weigh human health and environmental risks from antibiotic resistance before deciding on an emergency permit for florfenicol in Tasmanian salmon farming.

Salmon Tasmania has sought approval to use florfenicol to treat farmed salmon affected by bacterial disease. The drug was first used in Tasmania’s south-eastern waters in November last year under an emergency permit, after a bacterial disease contributed to the deaths of 15,000 tonnes of salmon in early 2025.

The APVMA revoked that permit in March, citing an “unacceptable risk of residue exposure to non-target species”. Traces of florfenicol had been detected in wild fish up to 10 kilometres from the nearest treated salmon pen, while the drug was later found in abalone up to 14km away.

The AMA said medicated feed used in salmon pens cannot be contained and that antibiotic exposure in aquatic environments can favour resistant bacteria. It called for a full assessment, including independent environmental and human-health evaluations made public, rather than repeated emergency permits.

Salmon Tasmania chief executive John Whittington said the industry agreed antimicrobial resistance was a serious global health issue. He said vaccination and selective breeding were the first line of defence, antibiotics were used only for diagnosed disease under veterinary prescription, and there was no routine or preventative antibiotic use in Tasmanian salmon farming. The APVMA is expected to decide on the request soon.

About the Author​

More
articles